Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4cdb1ef9fe36ae01e3729156a7103103 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-88 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403 |
filingDate |
2007-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af1c1d5da7379287756f6ad902df0b92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aff2d614139cb893af49ca35744dbb75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_699a394ab5d48651c81ffee11cf6920a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0156755cfe85ed4a7d9f2a85930bc07 |
publicationDate |
2007-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2007299123-A1 |
titleOfInvention |
Amorphous frovatriptan succinate and process for the preparation thereof |
abstract |
Frovatriptan succinate substantially in an amorphous form is disclosed. Also disclosed is a composition comprising frovatriptan succinate in a solid form, wherein at least about 80% by weight of the solid is frovatriptan succinate in an amorphous form. The present invention also provides a process for preparing frovatriptan succinate substantially in an amorphous form by providing a solution of frovatriptan succinate in one or more solvents capable of dissolving the frovatriptan succinate and substantially removing the solvent from the solution. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011224435-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010122343-A1 |
priorityDate |
2006-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |